ライフサイエンスコーパス: core biopsy

1 ignant lesions) were sampled at large-needle core biopsy.

2 ical subtype, which was definitely proved at core biopsy.

3 (7.7%) were diagnosed by FNA or stereotactic core biopsy.

4 f breast lesions removed during stereotactic core biopsy.

5 cancers and 12 in situ cancers, compared to core biopsy.

6 mas preoperatively sampled with stereotactic core biopsy.

7 consecutive women who underwent stereotaxic core biopsy.

8 rostate tissue before the initial systematic core biopsy.

9 esions underwent US or DCE MR imaging-guided core biopsy.

10 believed to have been accurately sampled at core biopsy.

11 se chain reaction (PCR) to detect KSHV in BM core biopsies.

12 e, and feasibility of obtaining preoperative core biopsies.

13 sampling and could help improve the yield of core biopsies.

14 3 + 4) compared with standard (systematic 12-core) biopsies.

15 sclerosing adenosis was the major finding at core biopsy (21 lesions at 14-gauge core biopsy and 12 a

16 ession by the osteoblasts in all bone marrow core biopsies (352 of 352, 100%).

17 en by either fine-needle aspiration (19/59), core biopsy (39/59), or lumpectomy (8/59) underwent SLN

18 re reimbursement costs of +385 for US-guided core biopsy, +610 for stereotactic core biopsy, and +1,3

19 s is the endothelial injury seen on protocol core biopsies after implantation.

20 were collected for 1121 patients undergoing core biopsies and 501 patients undergoing surgical biops

21 Targeted core biopsies and random systematic core biopsies were p

22 and resolution without the need for invasive core biopsies and substantially improve early detection

23 Medicare estimates of $472 for stereotactic core biopsy and $1,335 for surgical biopsy.

24 4% (76 of 373) of lesions diagnosed at large-core biopsy and 11.2% (107 of 953) of lesions diagnosed

25 nding at core biopsy (21 lesions at 14-gauge core biopsy and 12 at 11-gauge vacuum-assisted biopsy);

26 y, the cost would be reduced by 20% with the core biopsy and 39% with the sestamibi strategy.

27 ADH, 1058 (61.3%) of which were diagnosed by core biopsy and 635 (36.8%) by excisional biopsy.

28 t in 26 (48%) of 54 lesions sampled at large-core biopsy and in 13 (18%) of 74 lesions sampled at vac

29 rating carcinoma diagnosed with percutaneous core biopsy and obviated axillary dissection in 23 women

30 mpared sestamibi breast imaging, stereotaxic core biopsy and surgical biopsy as breast evaluation str

31 lated images with the histologic findings at core biopsy and then designating each core biopsy findin

32 US-guided core biopsy, +610 for stereotactic core biopsy, and +1,332 for needle localization and surg

33 as inadvertently removed during stereotactic core biopsy, and a 0.5- or 1.0-cm-long endovascular embo

34 Fine-needle aspiration biopsy and core biopsy are important procedures that may obviate su

35 -SIM images of 34 unfixed and uncut prostate core biopsies by two independent pathologists resulted i

36 Multiple FFPE core biopsies can be assembled in a single block to form

37 Image-guided core biopsy can be cost-saving compared with surgical bi

38 dance is achieved, women with ALH or LCIS at core biopsy can be observed.

39 for women whose ADH was diagnosed by needle core biopsy compared with excisional biopsy.

40 An initial core biopsy confirmed carcinoma in the breast.

41 A core biopsy confirmed invasive ductal carcinoma, grade 2

42 ostic imaging reveals a suspicious mass, and core biopsy confirms invasive ductal carcinoma (IDC) tha

43 graphic database review (1994-2003) revealed core biopsy diagnoses of benign papilloma (n=38), atypic

44 2 patients with ADH or benign but discordant core biopsy diagnoses.

45 went sentinel node biopsy after percutaneous core biopsy diagnosis of nonpalpable infiltrating breast

46 Core biopsy did not reveal malignancy in any of the nine

47 From the initial core biopsies, differential patterns of expression of 92

48 on, patients were randomly assigned to tumor core biopsy either before the first dose or after the th

49 ammography, ultrasonography, core technique, core biopsy, excision, and subsequent mammography.

50 ngs at core biopsy and then designating each core biopsy finding as concordant or discordant.

51 Vacuum-assisted core biopsy findings were compared with excisional biops

52 nce was observed in the likelihood of benign core biopsy findings without atypia in malignant calcifi

53 Of the 43 benign concordant core biopsy findings, none were upgraded at surgery (n =

54 Magnetic resonance images and core biopsy findings.

55 g adenosis proved to be a minor component at core biopsy for 44 lesions, including one invasive ducta

56 assisted 11- or 14-gauge needle stereotactic core biopsy for calcifications with malignant histologic

57 Core biopsies from 24 patients were obtained before trea

58 We studied paraffin-embedded bone marrow core biopsies from 39 patients with HCL in complete remi

59 was performed on tissue microarrays from 652 core biopsies from BC patients, who underwent NACT in th

60 Histological review was performed on liver core biopsies from native livers.

61 ates in transplant fine-needle aspirates and core biopsies from patients on this regimen without acut

62 ng history, lesion size, use of an automated core biopsy gun, number of needle passes, and frequency

63 The core biopsies had lymphocytes in 5-30% of the interstiti

64 opulation, one third of patients with ADH at core biopsy have an occult carcinoma.

65 nosis of DCIS after 14-gauge automated large-core biopsy in 373 lesions and after 14- or 11-gauge dir

66 esions in seven institutions and after large-core biopsy in 55 previously reported lesions.

67 he sensitivity, specificity, and accuracy of core biopsy in differentiating neoplastic (malignant and

68 The role of image-guided core biopsy in nonpalpable breast lesion evaluation is b

69 US-guided core biopsy in patients with head and neck lymphadenopat

70 ve in 16% (30 of 182) of lesions at 14-gauge core biopsy, in 4% (four of 96) of lesions at 14-gauge v

71 ochemical studies previously obtained on the core biopsy indicated that the tumor was positive for es

72 quencing of single-cell nuclei from prostate core biopsies is a rich source of quantitative parameter

73 Benign papilloma diagnosed at core biopsy is infrequently (3%) associated with maligna

74 Core biopsy is necessary if a diagnosis cannot be made w

75 Moving to a policy in which core biopsy is the preferred approach in these settings

76 bx), stereotactic 11-gauge suction-assisted core biopsy (Mammotome [Mbx]), stereotactic coring excis

77 od, use of minimally invasive methods (e.g., core biopsy) may be desirable for obtaining tissue sampl

78 um-assisted biopsy (mean, 34 mg) as at large-core biopsy (mean, 17 mg) (previously reported).

79 biopsy (mean, 15.8 specimens) than at large-core biopsy (mean, 9.7 specimens).

80 success rate with the traditional 14-gauge, core-biopsy, multiple-pass technique was compared with t

81 ecimens with known activity obtained using 2 core-biopsy needle sizes.

82 anced neuroblastoma by using 15- or 16-gauge core biopsy needles.

83 by competitive RT-PCR in 60 renal allograft core biopsies obtained for surveillance or to diagnose t

84 Core biopsies obtained using PET/CT guidance contain bou

85 US-guided core biopsy obviated a surgical procedure in 128 (85%) o

86 ermine the frequency with which stereotactic core biopsy obviated a surgical procedure.

87 Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with

88 May 3, 1994, and June 12, 1996, image-guided core biopsies of 510 mammographically identified lesions

89 Core biopsies of bone marrow showed a mean of 0.0029+/-0

90 Core biopsies of grafted areas were obtained in several

91 disease (MRD) can be detected in bone marrow core biopsies of patients with hairy cell leukemia (HCL)

92 Endobronchial ulstrasound-guided core biopsies of the lung mass and ipsilateral mediastin

93 Stereotactic core biopsy of a 4-5-mm, suspicious mammographic lesion

94 lerosing adenosis is an acceptable result at core biopsy of circumscribed masses and nonpalpable indi

95 Subsequently, a core biopsy of intrahepatic colorectal metastases was pe

96 was found for fine-needle aspiration versus core biopsy of malignant lesions (92% vs 86%), a statist

97 A 51-year-old woman underwent stereotactic core biopsy of suspicious microcalcifications in the upp

98 Core biopsy of the involved lymph node confirmed estroge

99 efore surgical resection, followed by needle-core biopsy of the optically measured tissue.

100 The Mayo Clinic diagnostic strategy utilizes core biopsy of the pancreas and the Japanese strategy de

101 A core biopsy of tumor and normal adjacent liver by using

102 ons, 18 (25%) were diagnosed as malignant at core biopsy; one (1%), as premalignant; 30 (42%), as spe

103 Sensitivity analysis showed core biopsy optimal in 95.4% of trials.

104 The projected cost savings of core biopsy or sestamibi imaging, compared to surgery, r

105 cost savings were realized with stereotactic core biopsy over open surgical biopsy for all mammograph

106 Overall cost savings for stereotactic core biopsy over open surgical biopsy was $741 per case.

107 a half to three times higher than those for core biopsy (P < .001).

108 Rapid assessment of prostate core biopsy pathology at the point-of-procedure could pr

109 to the results of one, two, and three 0.6-mm core biopsies per tumor on a tissue array.

110 ate of stereotactic vacuum-assisted 11-gauge core biopsies performed (P < .001).

111 al triglyceride extraction (n=117), and five core biopsies performed in each segment for histologic g

112 rized using the invasive percutaneous needle core biopsy procedure.

113 onse was assessed in 3-week post-therapeutic core biopsies (proliferation decrease >/= 30% Ki-67 or c

114 After a diagnosis of lobular neoplasia at core biopsy, residual microcalcifications are viewed in

115 concentration (tHb) and was correlated with core biopsy results.

116 Histological evaluation of the human bone core biopsies revealed normal bone tissue formation iden

117 Of 31 patients, stereotactic core biopsy revealed carcinoma in 19 (61%), atypical duc

118 %) were deemed poor donor candidates because core biopsy revealed subtle hepatic necrosis and nonspec

119 ostic ultrasound confirms a 1.8 cm mass, and core biopsy reveals IDC that is estrogen and progesteron

120 Triplicate 0.6-mm core biopsies sampled on tissue arrays provide a reliabl

121 Nineteen of 38 core biopsy samples contained cancer.

122 We took core biopsy samples from primary breast tumours in 24 pa

123 Ten full-depth core biopsy samples were obtained from patients who had

124 The number of core biopsy samples, glomeruli, and small arteries obtai

125 From the core biopsy samples, we extracted sufficient total RNA (

126 ent-derived xenografts were established from core biopsy samples.

127 Core-biopsy samples of normal bone marrow from the iliac

128 tage of TILs using hematoxylin-eosin-stained core biopsy sections taken at diagnosis (prior to treatm

129 cy (67%), diagnosis of atypical papilloma at core biopsy should prompt excision for definitive diagno

130 Stereotactic core biopsy showed a focus of invasive duct carcinoma, s

131 Nine core biopsies showing interstitial lymphocytic infiltrat

132 ant EBV-TK mRNA expression in a stereotactic core biopsy specimen from a solid organ transplant patie

133 vessels per millimeter length of bone marrow core biopsy specimen was scored by light microscopy.

134 nalyzed using tissue microarrays from needle core biopsy specimens and xenograft-bearing mouse models

135 uantified angiogenesis alone in pretreatment core biopsy specimens did not predict treatment response

136 es were analyzed using surgical material and core biopsy specimens from HCV-infected cirrhotic liver

137 The utility of saving core biopsy specimens in sterile gel tubes was evaluated

138 ow the detection of prostate cancer cells in core biopsy specimens with insufficient numbers of cells

139 (PgR) percentage expression (46 surgical, 2 core biopsy specimens) was performed.

140 as available for 44 patients (42 surgical, 2 core biopsy specimens).

141 serum PSA level, percentage of cancer in all core biopsy specimens, and endorectal MR imaging finding

142 age of cancer-positive core specimens in all core biopsy specimens, and presence of perineural invasi

143 tumor, greatest percentage of cancer in all core biopsy specimens, percentage of cancer-positive cor

144 ompared with tissue diagnoses from US-guided core biopsy specimens.

145 Performing QABS on core-biopsy specimens obtained using PET/CT guidance ena

146 ications, 1.8 times more frequent with large-core biopsy than with vacuum-assisted biopsy, and 1.5 ti

147 There were 9 needle-localized core biopsies that corresponded to MRI of metastatic les

148 develop prognostic factors derived from the core biopsy that may enhance the prediction of tumor bio

149 e identified 293 probe sets overexpressed in core biopsies; these included five highly coexpressed ge

150 -needle aspiration biopsy (eight lesions) or core biopsy (three lesions).

151 We used immunohistochemistry in bone marrow core biopsies to assess NCAM expression in osteoblasts a

152 tent malignancy is necessary for stereotaxic core biopsy to be optimally effective.

153 ry, histologic grading, and the relevance of core biopsy to diagnostic certainty are considered.

154 e 19 patients with carcinoma at stereotactic core biopsy, two chose to undergo a second biopsy surgic

155 rgical biopsy, one with DCIS at stereotactic core biopsy underwent axillary dissection after invasion

156 assisted biopsy, ultrasonography (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, su

157 an adjusted direct cost saving per US-guided core biopsy was +744 per case.

158 gnancy can be seen with sclerosing adenosis; core biopsy was accurate in six (86%) of seven coexisten

159 Diagnosis at stereotactic core biopsy was carcinoma in 116 (81%) lesions, atypical

160 Core biopsy was favored for low-suspicion lesions, calci

161 yielded atypical hyperplasia at stereotactic core biopsy was higher for calcifications than masses (3

162 , clinical measurements were repeated, and a core biopsy was obtained and prepared for histologic eva

163 s (average: 18.2 weeks), and a 2-mm-diameter core biopsy was obtained before implant placement.

164 e reentered at the appropriate healing time, core biopsy was obtained, and a dental implant was place

165 US-guided core biopsy was performed in 151 consecutive solitary, n

166 Per 1000 women, core biopsy was projected to miss about seven invasive a

167 A 2-mm-diameter core biopsy was taken from each grafted site approximate

168 Fine-needle aspiration (FNA) or stereotactic core biopsy was used to diagnose 195 of the 422 patients

169 Stereotactic core biopsy washings and blood drop samples, routinely d

170 keratin-positive (epithelial) cells from the core biopsy washings were sorted by means of flow cytome

171 Core biopsies were assessed by immunohistochemistry for

172 At the time of implant placement, bone core biopsies were harvested using the radiographic-surg

173 ed to heal for 18 to 20 weeks, at which time core biopsies were obtained and dental implants were pla

174 Breast core biopsies were obtained at baseline and after 2 mont

175 Approximately 20 weeks after grafting, core biopsies were obtained during implant placement and

176 al measurements were performed, and trephine core biopsies were obtained for histomorphometric analys

177 linical measurements were repeated, and bone core biopsies were obtained for histomorphometric analys

178 Two hundred sixty US-guided core biopsies were performed in 247 patients with cervic

179 Targeted core biopsies and random systematic core biopsies were performed.

180 Sequential core biopsies were taken at baseline and within weeks 1

181 Histologic findings at core biopsy were correlated with mammographic findings,

182 olitary invasive breast cancers diagnosed at core biopsy were treated with US-guided cryoablation and

183 etting, then sestamibi imaging or sterotaxic core biopsy will lead to substantial cost savings compar

184 rmalin-fixed, paraffin-embedded tissues from core biopsies with a tumor cell content of >/= 20% by us

185 Stereotactic core biopsy with an automated gun obviated a surgical pr

186 ications who underwent 14-gauge stereotactic core biopsy with an automated gun.

187 ably at vacuum-assisted biopsy than at large-core biopsy (with no increase in complications) with mos

188 ductal carcinoma considered grade 2 of 3 on core biopsy, with a positive fine-needle aspiration of a

189 Two hundred thirty-eight (92%) core biopsies yielded adequate material.

190 database was searched from 2000 to 2010 for core biopsies yielding ALH or LCIS devoid of any additio